News

Gladstone in the News April 21, 2025

SF100: The Standard’s Highly Subjective, Nearly Definitive, Surely Divisive List of Who Holds Power, Influence, and Attention in San Francisco in 2025

The San Francisco Standard—The San Francisco Standard published a list of 100 of the most influential, powerful, and culturally relevant people in San Francisco. Gladstone President Deepak Srivastava was named to the list as one of “The Solvers”, who, in a city full of old challenges, are finding new solutions. Srivastava was recognized due to his leadership of leading scientists searching for breakthroughs in immunology, stem cells, neurodegenerative diseases, HIV, and cancer.  

Gladstone Experts Srivastava Lab

Gladstone in the News March 3, 2025

In Conversation with Dr. Deepak Srivastava, President of Gladstone Institutes

The San Francisco Experience—In a podcast interview, Gladstone President Deepak Srivastava discusses the mission of Gladstone Institutes, and describes how advances in stem cell biology, genome engineering, and artificial intelligence are making it possible to understand the core of diseases and develop new cures.

Gladstone Experts Srivastava Lab AI CRISPR/Gene Editing Stem Cells/iPSCs

Video February 12, 2025

A Revolution in Medicine: The Science Fueling a New Age of Cures

Watch a recording from Deepak Srivastava's presentation at the Commonwealth Club World Affairs.

Office of the President Gladstone Experts Srivastava Lab

Gladstone in the News January 1, 2025

Closer to Cures at San Francisco’s Gladstone Institutes

Nob Hill Gazette—Gladstone President Deepak Srivastava shines a light on Gladstone’s science, collaborative culture, and mission. He also shares extremely good news: the cures for catastrophic diseases like cancer, Parkinson’s, heart disease, and HIV are remarkably close.

Gladstone Experts Institutional News Srivastava Lab

Article November 14, 2024

Gladstone President Deepak Srivastava Named 2024 Distinguished Citizen by Commonwealth Club World Affairs

Srivastava is recognized for his organizational leadership, scientific innovation, and impact on the future of medicine.

Awards Srivastava Lab

Article October 23, 2024

Gladstone Researchers Discover How Chronic Inflammation Worsens Heart Failure

The new findings have implications for developing immune therapies that target heart disease and chronic conditions in other organs.

News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava Lab

Gladstone in the News September 16, 2024

Guest Opinion: How Should We Pay for New Breakthrough Cures?

San Francisco Business Times—The world’s first CRISPR-based drug that alters the genetic code is on the market. Thousands of other therapies using gene editing or stem cell technologies are in the works and offer potential cures. But how will society pay for these life-saving drugs? In this opinion piece, Gladstone President Deepak Srivastava shares his views on a new world of medical possibilities.

Gladstone Experts Srivastava Lab

Gladstone in the News July 19, 2024

San Francisco Scientists Using AI in Hopes to Better Treat Cancer

ABC7 News—Gladstone's president Deepak Srivastava, and Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, explain how scientists are using artificial intelligence to pinpoint the best ways to treat cancer.

Gladstone Experts Cancer Data Science and Biotechnology Pollard Lab Srivastava Lab AI

Gladstone in the News June 12, 2024

Podcast: ’The Voice Weekly’ Featuring Deepak Srivastava

The Voice of San Francisco—Gladstone President Deepak Srivastava, MD, talks about technologies driving the next wave of medicine, the importance of philanthropy dollars in fueling scientific breakthroughs, and how biotech is still breathing life into San Francisco's Mission Bay neighborhood.

Philanthropy Srivastava Lab Aging AI CRISPR/Gene Editing Stem Cells/iPSCs

Article May 10, 2024

Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times

The San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership role at Gladstone Institutes since 2018.

Awards Institutional News News Release Congenital Heart Disease Cardiovascular Disease Srivastava Lab

Gladstone in the News December 3, 2023

Genetic Mechanisms Linking Maternal Diabetes and Birth Defects Uncovered

Genetic Engineering & Biotechnology News—In addition to genetic changes, environmental factors are associated with the development of birth defects. A new study led by Deepak Srivastava, president of Gladstone Institutes, reveals how maternal diabetes alters a small subset of cells in the developing heart in a way that can lead to congenital heart defects.

Gladstone Experts Congenital Heart Disease Diabetes Cardiovascular Disease Srivastava Lab Single Cell

Article November 30, 2023

Gladstone Team Uncovers Why Maternal Diabetes Predisposes Babies to Heart Defects

The cutting-edge research methods that led to the discovery could be used to find other connections between environmental factors and birth defects.

News Release Research (Publication) Cardiovascular Disease Srivastava Lab

Article November 13, 2023

American Heart Association Honors Gladstone President Deepak Srivastava with Distinguished Scientist Award

The award recognizes leaders who have made major contributions to the fields of cardiovascular and stroke science

Awards News Release Cardiovascular Disease Srivastava Lab

Gladstone in the News November 7, 2023

Special Episode: JAHA Distinguished Hearts and Minds Roundtable

AHA with JAHA Podcast—In a roundtable forum, the American Heart Association’s 2023 Distinguished Scientists describe their contributions to stroke and cardiovascular research. Gladstone President Deepak Srivastava discusses the use of human iPS cells in drug discovery and his hopes for the future of science and medicine, including applications of artificial intelligence.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Human Genetics Stem Cells/iPSCs

Article September 27, 2023

When Two Disruptive Technologies Converge

How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine

Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab